Mackenzie Financial
ASMB icon

Mackenzie Financial’s Assembly Biosciences ASMB Stock Holding History

Mackenzie Financial’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-583
Closed -$274K – 1105
2018
Q2 		$274K Hold
583
– – ﹤0.01% 909
2018
Q1 		$344K Sell
583
-794
-58% -$492K ﹤0.01% 788
2017
Q4 		$748K Hold
1,377
– – ﹤0.01% 633
2017
Q3 		$577K Buy
+1,377
New +$422K ﹤0.01% 507

Other funds holding ASMB

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Mackenzie Financial's ASMB Position: Q3 2018 in Review

Mackenzie Financial sold out of Assembly Biosciences (ASMB) in Q3 2018, closing a stake of 583 shares — an estimated $274K sold.

Mackenzie Financial first reported a position in ASMB in Q3 2017 and held it in 4 quarters. The position peaked at $748K in Q4 2017. 113 funds tracked by Wall St. Rank hold ASMB as of Q3 2018.

  • Mackenzie Financial reported no remaining Assembly Biosciences position as of Q3 2018 after selling out during the quarter.
  • Mackenzie Financial sold 583 Assembly Biosciences shares in Q3 2018, an estimated $274K.
  • Mackenzie Financial first reported a position in Assembly Biosciences in Q3 2017 and held it in 4 quarters.
  • Mackenzie Financial's Assembly Biosciences position peaked at $748K in Q4 2017.
  • 113 funds tracked by Wall St. Rank held Assembly Biosciences as of Q3 2018.

Based on Mackenzie Financial's 13F filing for Q3 2018, filed 15 Nov 2018.